Page 133 - Buku Panduan Perkhidmatan MKAKB
P. 133

1.      INTRODUCTION

                           International  and  national  procedures  have  been  established  for  the  safe  transport  of
                           biological  materials  by  all  modes  of  transportation  (air,  sea  and  land).  Different  packaging
                           and transport arrangement apply depending on whether materials are infectious substances,
                           biological  products,  cultures,  genetically  modified  organism  (GMO)  or  exempt  substances.
                           The  requirements  of  various  regulatory  bodies  are  based  on  the  United  Nations
                           Recommendations  on  the  Transport  of  Dangerous  Goods  Model  Regulations  which  are
                           adopted  by  International  Air  Transportation  Association  (IATA)  and  Malaysian  Standards
                           (MS1513).

                           It  is  the  responsibility  of  sender  to  ensure  compliance  with  all  packaging  and  transport
                           regulations.

                   2.      OBJECTIVE

                           This  procedure  is  to  ensure  proper  and  safe  transport  of  all  biological  materials  including
                           environmental samples such as patients’ specimens, infectious substances, cultures, water
                           samples, clinical wastes and genetically modified organisms for all modes of transportation
                           (air, sea and land) to referral or other laboratories.

                           This  procedure  also  ensures  that  the  integrity  of  the  specimens  is  preserved  for  accurate
                           analysis by the receiving laboratory.

                   3.      SCOPE

                           This procedure will be used for packing and transporting of patients’ specimens, infectious
                           substances, cultures, clinical wastes and genetically modified organisms to the designated
                           Referral Laboratory in Malaysia and overseas.

                   4.      DEFINITION

                          The following definitions align with the UN Model Regulations and are used in this Section:

                           4.1    Biological products

                                  Products  that  are  derived  from  living  organisms,  used  either  for  prevention,
                                  treatment,  or  diagnosis  of  diseases  in  humans  or  animals,  or  for  developmental,
                                  experimental or investigational purposes.

                          4.2     Patients’specimens:

                                  Those collected directly from humans or animals, including, but not limited to, excreta
                                  (feces  &  urine),  secreta  (body  fluids),  blood  and  its  components,  tissue  (including
                                  fresh tissue, preserved tissue, paraffin blocks and glass slides) and swabs, and body
                                  parts  being  transported  for  purposes  such  as  diagnosis,  research,  investigational
                                  activities, disease treatment and prevention.

                          4.3     Cultures:

                                  The result of a process by which living organisms are intentionally propagated. This
                                  definition does not include patient specimens.

                          4.4     Dangerous Goods:
   128   129   130   131   132   133   134   135   136   137   138